| ORCHID PHARMA  | 
The Current P/B Ratio of ORCHID PHARMA  is 2.84.
                
| Share Price | ₹709.2 | Oct 30,2025 | 
| Market Cap | ₹3,595.6 Cr | |
| Book Value | ₹1,267.3 Cr | Mar2025 - Consolidated Results | 
| Price/Book | 2.84x | Calculated as MarketCap/Book Value | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of ORCHID PHARMA
                    P/B = 
                    Market Capitalization 
                    / Book Value 
                    
                    or, using per-share numbers:
                    
                    P/B = Stock Price / 
                    Book Value Per Share 
                
               
                                     Current Market Cap [ ₹3,595.6 Cr] as on Oct 30,2025                     
                    (/) Book Value [ ₹1,267.3 Cr] based on Mar2025 - Consolidated Results
                                    
                
                (=) P/B Ratio [ 2.84x ]
            
Thus, for ORCHID PHARMA , the investors are currently willing to pay '2.84 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of ORCHID PHARMA !
The chart below summarizes the trend in P/B Ratio of ORCHID PHARMA over the last five years.
Historical PB (Price/Book ) ratio chart of ORCHID PHARMA
PB Ratio Performance Analysis for ORCHID PHARMA
- ORCHID PHARMA 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 5.42x.
- ORCHID PHARMA 's operated at median p/b ratio of 3.11x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ORCHID PHARMA 's p/b ratio peaked in Mar2021 at 15.41x.
- ORCHID PHARMA 's p/b ratio hit its five-year low in Mar2022 of 1.79x.
How does ORCHID PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap | 
|---|---|---|---|
| ORCHID PHARMA | 1,267.29 | 2.84 | 3,595.6 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.66 | 408,751.0 | 
| DIVIS LABORATORIES LTD | 14,969.00 | 11.80 | 176,634.0 | 
| CIPLA LTD | 31,079.30 | 4.00 | 124,437.0 | 
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.06 | 121,871.0 | 
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.00 | 100,333.0 | 
| MANKIND PHARMA LTD | 14,288.70 | 7.07 | 100,950.0 | 
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.14 | 99,244.9 | 
| LUPIN LTD | 17,119.50 | 5.19 | 88,847.7 | 
| AUROBINDO PHARMA LTD | 32,653.30 | 1.96 | 64,033.4 | 
| ABBOTT INDIA LTD | 4,204.27 | 14.98 | 62,972.6 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs ORCHID PHARMA 's P/B Ratio
| Top 10 Industry Peers | PB Ratio | 
|---|---|
| Min industry PB | 1.96x | 
| Max industry PB | 16.06x | 
| Median industry PB | 5.19x | 
| Average industry PB | 6.97x | 
You may also like the below Video Courses
 
                                     
                                     
                                    